|Acquired by||Intercytex Group|
|Phone||44 1142 224 550|
Axordia Limited researches human stem cells in order to develop therapeutic treatments for debilitating diseases, such as heart disease, liver failure, Parkinson’s and multiple sclerosis. The company was formerly known as Cellbiosys Limited and changed its name to Axordia Limited in May, 2001. The company was incorporated in 1999 and is based in Sheffield, United Kingdom. As of December 22, 2008, Axordia Limited operates as a subsidiary of Intercytex Group Plc.